non responders to semaglutide When Weight-Loss Drugs Don't Work Semaglutide as a GLP-1 Agonist:

Typical doses range from 1000 mg to 2000 mg daily, ideally taken before exercise for maximum fat-burning

It found that almond consumption impacted appetite-regulating hormones, such as glucose-dependent insulinotropic polypeptide, glucagon and pancreatic polypeptide

While its true that these medications originated as treatments for type 2 diabetes and pre-diabetes, both semaglutide and tirzepatide are also FDA-approved to treat obesity

References: (1) P B Johansen, J Nowak, C Skjrbk, et al (1999) Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats Growth Hormone & IGF Research, Volume 9, Issue 2, May 1999, Pages 106-113

The compounds every alternative is built on Whichever brand you choose, the pharmacology comes from the same short list